| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | WGS Genedx Holdings Corp. | Meister Keith A.63 | Director, 10% Owner | Buy | 50,000 | $60.16 | $3,007,997.24 | +0.8% | +95.8% | - | |
| May 14, 2025 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 140 | $140.73 | $19,702.90 | -0.5% | +9.9% | - | |
| May 13, 2025 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 500 | $145.41 | $72,705.00 | -2.5% | +3.4% | - | |
| May 13, 2025 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 992 | $0.36 | $353.30 | -0.2% | +8.7% | +103.8% | |
| May 13, 2025 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 445 | $0.36 | $158.49 | -0.1% | +8.7% | +103.8% | |
| May 13, 2025 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 477 | $0.36 | $169.89 | -0.2% | +8.7% | +103.8% | |
| May 13, 2025 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,775 | $0.36 | $1,344.47 | -0.3% | +8.7% | +103.8% | |
| May 13, 2025 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 224 | $0.36 | $79.78 | -0.6% | +8.7% | +103.8% | |
| May 12, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 400 | $411.11 | $164,444.00 | -1.7% | +6.9% | +6.2% | |
| May 12, 2025 | DHR Danaher Corp /de/ | Rales Steven M58 | Chairman | Sell | 1,250,000 | $196.74 | $245,919,390.92 | -4.2% | -0.5% | -17.2% | |
| May 12, 2025 | CDNA Caredx, Inc. | Cournoyer Christine51 | Director | Sell | 29,136 | $15.96 | $465,022.21 | -44.0% | -28.1% | +30.8% | |
| May 12, 2025 | NEO Neogenomics Inc | Stone Warren | Pres &Chief Operating Officer | Buy | 5,700 | $8.58 | $48,894.60 | +5.6% | -31.6% | +2.8% | |
| May 12, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,070 | $159.25 | $966,632.61 | -0.3% | -0.2% | +29.8% | |
| May 9, 2025 | NEO Neogenomics Inc | Tetrault Lynn A. | Director | Buy | 7,000 | $8.14 | $56,974.40 | New | -28.4% | +11.3% | |
| May 8, 2025 | WGS Genedx Holdings Corp. | Meister Keith A.63 | Director, 10% Owner | Buy | 100,000 | $56.01 | $5,600,994.47 | +1.1% | +87.8% | -27.7% | |
| May 8, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 20,000 | $32.31 | $646,260.00 | -7.6% | -20.6% | +74.3% | |
| May 7, 2025 | NEO Neogenomics Inc | Kanovsky Stephen M | Director | Buy | 4,000 | $7.78 | $31,124.40 | +11.1% | -29.8% | +13.4% | |
| May 7, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 5,000 | $32.72 | $163,590.00 | -4.5% | -16.0% | +78.6% | |
| May 6, 2025 | NEO Neogenomics Inc | Zook Anthony P. | Chief Executive Officer | Buy | 18,900 | $7.88 | $148,918.77 | New | -26.3% | +15.6% | |
| May 6, 2025 | CDNA Caredx, Inc. | Cournoyer Christine51 | Director | Sell | 16,700 | $14.13 | $235,929.25 | -31.1% | -11.1% | +47.7% | |
| May 5, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,800 | $37.65 | $105,422.80 | -1.1% | -15.9% | +57.8% | |
| May 5, 2025 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 162 | $37.65 | $6,099.46 | -0.3% | -15.9% | +57.8% | |
| May 5, 2025 | NEO Neogenomics Inc | Gunn Neil | Director | Buy | 4,510 | $7.75 | $34,977.45 | +39.8% | -27.7% | +13.0% | |
| May 5, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 689 | $37.65 | $25,941.54 | -0.6% | -15.9% | +57.8% | |
| May 5, 2025 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 2,688 | $14.70 | $39,513.60 | -2.2% | -16.9% | +36.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.